RADIENT PHARMACEUTICALS CORPORATION
Company News Products Distribution Resources Investor Contact
About Radient Pharmaceuticals

Radient Pharmaceuticals Corporation is a vertically integrated pharmaceutical company with distinct business divisions:

  • Manufacturer and Distributor ofOnko-Sure™ a Proprietary InVitro Diagnostic (IVD) Cancer Test;
  • Distribution of Elleuxe brand of Anti-Aging Skin Care Products;
  • A China-based Pharmaceutical Manufacturing and Distribution; and
  • A Cancer Therapeutics Technology

Message from The Chairman & CEO
In late September 2009 we began launching the re-branding our Company and we have a New Ticker Symbol “RPC” listed on the NYSE’s AltNext Exchange. Our new focus is to be involved with “Things that Matter”.  We make products that make a difference in people’s lives – thing like life saving cancer detection and cell-renewing skin care products.

 

Click here or the image to launch the video

View the Powerpoint Presentation

In the News

April 22, 2010
Radient Pharmaceutical Expands Onko-Sure Commercialization To Include Clia Lab-Based Testing Services» More

April 21, 2010
Radient Pharmaceutical To Present Onko-Sure™ Cancer Test At Prestigious Annual Oncology Conference» More

April 16, 2010
Radient Pharmaceutical Reports Third Closing Of Convertible Note Offering, 2009 Year End Results And Fiscal Year 2010 Targets» More

April 14, 2010
Advantages of Radient Pharmaceuticals’ Onko-Sure In Vitro Diagnostic Cancer Test Over CEA Published In Journal Of Immunoassay And Immunochemistry»More

April 13, 2010
Radient Pharmaceutical Completes Second Closing Of Convertible Promissory Note Financing» More

April 12, 2010
Radient Pharmaceutical Monetizing China-Based JADE Pharmaceutical Division» More

April 9, 2010
Radient Pharmaceuticals Expands Distribution Partnership With Genway Biotech; Company To Commercialize RPC’s Onko-Sure Cancer Test In Russia And Former Soviet Republics » More

April 8, 2010
Radient Pharmaceuticals Extends Onko-Sure Cancer Test Distribution Partnership For The Market Of India That Includes Use As A General Cancer Screen » More

April 7, 2010
Radient Pharmaceuticals Enters Into Collaboration With Jaiva Technologies To Advance Commercialization Of Radient's CIT™ Cancer Vaccine In India » More